[1]
A. AGUIRRE PÉREZ, A. Avila-Luna, A. Olmos-Hernández, A. Verduzco-Mendoza, J. A. Arias-Montaño, and A. Bueno-Nava, “antidyskinetic effect of the H₃ agonist immepip is accompanied by a reduction in thalamic GABA levels in hemiparkinsonian rats chronically treated with L-DOPA”, Invest. Discapacidad, vol. 11, no. S1, Nov. 2025.